The Ambifect version of the new trial drug builds on Akston's anti-cPD-L1 mAb, designed to target and block the cPD-L1 protein on cancer cells, which is currently in clinical trial for dogs with ...
The research draws on an extraordinary group of dogs studied through the Exceptional Aging in Rottweilers Study, led by ...
Series: Purdue leads 8-4 under Matt Painter but has dropped four in a row, including the 70-68 loss in Piscataway in December when the Boilermakers were ranked No. 1. The four-game losing streak is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback